Evaxion Biotech AS (EVAX)
4.18
+0.06
(+1.46%)
USD |
NASDAQ |
Apr 26, 16:00
4.13
-0.05
(-1.20%)
After-Hours: 20:00
Evaxion Biotech Total Return Level: 4.18 for April 26, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 26, 2024 | 4.18 |
April 25, 2024 | 4.12 |
April 24, 2024 | 4.13 |
April 23, 2024 | 4.14 |
April 22, 2024 | 4.19 |
April 19, 2024 | 4.31 |
April 18, 2024 | 4.22 |
April 17, 2024 | 4.11 |
April 16, 2024 | 4.04 |
April 15, 2024 | 4.10 |
April 12, 2024 | 4.10 |
April 11, 2024 | 3.89 |
April 10, 2024 | 3.99 |
April 09, 2024 | 3.96 |
April 08, 2024 | 4.09 |
April 05, 2024 | 3.69 |
April 04, 2024 | 3.65 |
April 03, 2024 | 3.60 |
April 02, 2024 | 3.88 |
April 01, 2024 | 3.23 |
March 28, 2024 | 3.20 |
March 27, 2024 | 3.00 |
March 26, 2024 | 3.13 |
March 25, 2024 | 3.10 |
March 22, 2024 | 3.05 |
Date | Value |
---|---|
March 21, 2024 | 3.05 |
March 20, 2024 | 3.03 |
March 19, 2024 | 3.07 |
March 18, 2024 | 3.08 |
March 15, 2024 | 2.99 |
March 14, 2024 | 2.95 |
March 13, 2024 | 3.03 |
March 12, 2024 | 3.02 |
March 11, 2024 | 3.12 |
March 08, 2024 | 3.10 |
March 07, 2024 | 2.94 |
March 06, 2024 | 2.90 |
March 05, 2024 | 3.02 |
March 04, 2024 | 3.19 |
March 01, 2024 | 3.39 |
February 29, 2024 | 3.60 |
February 28, 2024 | 3.66 |
February 27, 2024 | 3.60 |
February 26, 2024 | 3.76 |
February 23, 2024 | 3.78 |
February 22, 2024 | 3.83 |
February 21, 2024 | 3.88 |
February 20, 2024 | 3.99 |
February 16, 2024 | 4.05 |
February 15, 2024 | 4.15 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.90
Minimum
Mar 06 2024
126.80
Maximum
Nov 04 2021
31.19
Average
22.08
Median
Nov 28 2022
Total Return Level Benchmarks
Ascendis Pharma A/S | 135.90 |
DBV Technologies SA | 0.682 |
Cellectis SA | 2.506 |
Adaptimmune Therapeutics PLC | 1.075 |
Akari Therapeutics PLC | 1.185 |